VivoSeq
Other

Intrauterine Insemination

0

Pipeline Programs

1

Active Trials

2

Companies Involved

Intrauterine Insemination is an early-stage landscape with 0 programs across 2 companies. The most active players are Ferring, Merck & Co..

Pipeline Metrics

Competitive Density

6/100

Pipeline Velocity

6/100

Mech. Concentration

N/A

Completion Rate

92/100

Attrition Rate

7/100

Competitive Landscape

Bubble size = clinical trials

Approved
Phase 3
Phase 2
Phase 1
Preclinical

Top Companies Companies ranked by the number of pipeline programs they run for this disease.

Programs by Phase

No pipeline programs currently tracked for this disease.

Trial Status

14

clinical trials

Completed11 · 79%
Unknown status1 · 7%
Terminated1 · 7%
Recruiting1 · 7%

Trial Activity

14 trials

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)